Intervention Review

Acamprosate for alcohol dependence

  1. Susanne Rösner1,*,
  2. Andrea Hackl-Herrwerth2,
  3. Stefan Leucht2,
  4. Philippe Lehert3,
  5. Simona Vecchi4,
  6. Michael Soyka1

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 7 SEP 2010

Assessed as up-to-date: 29 JUL 2009

DOI: 10.1002/14651858.CD004332.pub2


How to Cite

Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD004332. DOI: 10.1002/14651858.CD004332.pub2.

Author Information

  1. 1

    University of Munich, Psychiatric Hospital, Munich, Germany

  2. 2

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  3. 3

    University of Mons, Statistics & Computer Sciences Dept, Mons, Belgium

  4. 4

    ASL RM/E, Department of Epidemiology, Rome, Italy

*Susanne Rösner, Psychiatric Hospital, University of Munich, Nußbaumstr. 7, Munich, 80336, Germany. susanne.roesner@med.uni-muenchen.de. susan.roesner@web.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 SEP 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrea M. Wessell, Lynne S. Nemeth, Ruth G. Jenkins, Steven M. Ornstein, Peter M. Miller, Medications for Alcohol Use Disorders in a Primary Care Practice-Based Research Network Implementation Study, Alcoholism Treatment Quarterly, 2014, 32, 1, 58

    CrossRef

  2. 2
    Shaun Yon-Seng Khoo, Robyn Mary Brown, Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?, CNS Drugs, 2014, 28, 8, 713

    CrossRef

  3. 3
    George E. Woody, Progress in Addiction Treatment: From One-Size-Fits-All to Medications and Treatment Matching, Substance Abuse, 2014, 35, 2, 110

    CrossRef

  4. 4
    Verena E. Metz, Laura Brandt, Annemarie Unger, Gabriele Fischer, Substance Abuse/Dependence Treatment: A European Perspective, Substance Abuse, 2014, 35, 3, 309

    CrossRef

  5. 5
    Andrew J Baillie, Claudia Sannibale, Lexine A Stapinski, Maree Teesson, Ronald M Rapee, Paul S Haber, An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol, BMC Psychiatry, 2013, 13, 1, 199

    CrossRef

  6. 6
    Alejandro Orrico, Lucía Hipólito, María José Sánchez-Catalán, Lucía Martí-Prats, Teodoro Zornoza, Luis Granero, Ana Polache, Efficacy of d-penicillamine, a sequestering acetaldehyde agent, in the prevention of alcohol relapse-like drinking in rats, Psychopharmacology, 2013, 228, 4, 563

    CrossRef

  7. 7
    Christian A. Müller, Andreas Heinz, Entzug geschafft — was kommt jetzt?, MMW - Fortschritte der Medizin, 2013, 155, 8, 63

    CrossRef